[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain
- PMID: 15900511
- DOI: 10.1007/s00210-005-1036-8
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain
Abstract
LY334370 is a high affinity, selective agonist at the 5-HT(1F) receptor. On this basis, the tritiated compound was examined for its utility in autoradiography to localize the 5-HT(1F) receptor in rat and guinea pig brain regions. Specific 5-HT(1F) receptor binding in rat brain was found in layers 4-5 of all cortical regions examined, as well as olfactory bulb and tubercle, nucleus accumbens, caudate putamen, parafascicular nucleus of the thalamus, medial mammillary nucleus, the CA3 region of the hippocampus, subiculum, and several amygdaloid nuclei. In guinea pig brain, the [(3)H]LY334370 binding sites were found at highest density in claustrum, but also in a layer of the cortex, caudate putamen, nucleus accumbens, thalamus, and medial mammillary nucleus. Some species differences in the distribution of the 5-HT(1F) receptor were noted. Side by side comparison of rat brain autoradiography with [(3)H]LY334370 and [(3)H]sumatriptan showed labeling in the same brain regions. Preliminary binding studies in rhesus monkey and human brain sections showed [(3)H]LY334370 binding in cortical layers 4-5, subiculum (in the monkey), and the granule cell layer of the cerebellum. These findings suggest a discrete localization of the 5-HT(1F) receptor in the rat, guinea pig, monkey and human brain, and confirms the utility of [(3)H]LY334370 as a potential tool to explore further the localization and possible functions of the 5-HT(1F) receptor.
Similar articles
-
G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.Br J Pharmacol. 1998 May;124(2):283-90. doi: 10.1038/sj.bjp.0701832. Br J Pharmacol. 1998. PMID: 9641544 Free PMC article.
-
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties.Naunyn Schmiedebergs Arch Pharmacol. 2005 Mar;371(3):169-77. doi: 10.1007/s00210-005-1035-9. Epub 2005 Apr 27. Naunyn Schmiedebergs Arch Pharmacol. 2005. PMID: 15900510
-
[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.Naunyn Schmiedebergs Arch Pharmacol. 1995 Sep;352(3):263-75. doi: 10.1007/BF00168556. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8584041
-
A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands.Brain Res Mol Brain Res. 1994 Jan;21(1-2):19-29. doi: 10.1016/0169-328x(94)90374-3. Brain Res Mol Brain Res. 1994. PMID: 8164519
-
Localization of specific binding sites for atrial natriuretic factor in the central nervous system of rat, guinea pig, cat and human.Brain Res. 1987 Jun 2;412(2):329-42. doi: 10.1016/0006-8993(87)91140-1. Brain Res. 1987. PMID: 2955851 Review.
Cited by
-
5-HT radioligands for human brain imaging with PET and SPECT.Med Res Rev. 2013 Jan;33(1):54-111. doi: 10.1002/med.20245. Epub 2011 Jun 14. Med Res Rev. 2013. PMID: 21674551 Free PMC article. Review.
-
The 5-HT1F receptor as the target of ditans in migraine - from bench to bedside.Nat Rev Neurol. 2023 Aug;19(8):489-505. doi: 10.1038/s41582-023-00842-x. Epub 2023 Jul 12. Nat Rev Neurol. 2023. PMID: 37438431 Review.
-
Brain serotonergic circuitries.Dialogues Clin Neurosci. 2010;12(4):471-87. doi: 10.31887/DCNS.2010.12.4/ycharnay. Dialogues Clin Neurosci. 2010. PMID: 21319493 Free PMC article.
-
Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review.Drug Healthc Patient Saf. 2021 Nov 23;13:233-240. doi: 10.2147/DHPS.S304373. eCollection 2021. Drug Healthc Patient Saf. 2021. PMID: 34849034 Free PMC article. Review.
-
The Neuropsychiatric Safety Profile of Lasmiditan: A Comparative Disproportionality Analysis with Triptans.Neurotherapeutics. 2023 Sep;20(5):1305-1315. doi: 10.1007/s13311-023-01404-1. Epub 2023 Jul 12. Neurotherapeutics. 2023. PMID: 37436579 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous